TR199902963T2 - 5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip - Google Patents

5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip

Info

Publication number: TR199902963T2
Authority: TR; Turkey
Prior art keywords: dion; thiazolidine; pyridyl; ethoxy; benzyl
Prior art date: 1997-06-05

Application number

TR1999/02963T

Other languages

English (en)

Turkish (tr)

Inventor

Patel Jai

Ross Hamish

Price Robin

Roger Granett Jeffrey

Nigel Wray Paul

Original Assignee

Smithkline Beecham P.L.C.

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-02-21

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P.L.C., Smithkline Beecham Corporation filed Critical Smithkline Beecham P.L.C.

2000-02-21 Publication of TR199902963T2 publication Critical patent/TR199902963T2/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

TR1999/02963T 1997-06-05 1998-06-02 5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip TR199902963T2 (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
TR199902963T2 true TR199902963T2 (xx)	2000-02-21

Family

ID=26311662

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TR1999/02963T TR199902963T2 (xx)	1997-06-05	1998-06-02	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip
TR2000/02790T TR200002790T2 (tr)	1997-06-05	1998-06-02	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
TR2000/02790T TR200002790T2 (tr)	1997-06-05	1998-06-02	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (es)
JP (1)	JP2001521553A (es)
KR (1)	KR20010013410A (es)
CN (3)	CN1526391A (es)
AP (1)	AP1214A (es)
AR (2)	AR015120A1 (es)
AU (1)	AU8215098A (es)
BG (1)	BG104048A (es)
BR (1)	BR9810405A (es)
CA (2)	CA2292629C (es)
CO (1)	CO4940400A1 (es)
DZ (1)	DZ2510A1 (es)
EA (1)	EA002384B1 (es)
GB (1)	GB9711683D0 (es)
HU (1)	HUP0004070A3 (es)
ID (1)	ID24264A (es)
IL (1)	IL133074A0 (es)
MX (1)	MXPA99011322A (es)
NO (2)	NO995938L (es)
NZ (2)	NZ523725A (es)
OA (1)	OA11306A (es)
PE (1)	PE78899A1 (es)
PL (1)	PL337201A1 (es)
SK (1)	SK164899A3 (es)
TR (2)	TR199902963T2 (es)
TW (1)	TW570797B (es)
UY (1)	UY25032A1 (es)
WO (1)	WO1998055122A1 (es)
ZA (2)	ZA984826B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20010040A1 (es)	1999-04-23	2001-03-10	Smithkline Beecham Plc	Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
ATE246191T1 (de)	1999-04-23	2003-08-15	Smithkline Beecham Plc	Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
AU2002350965A1 (en) *	2001-12-13	2003-06-23	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE06252444T8 (de) *	2006-05-09	2009-03-19	Teva Pharmaceutical Industries Ltd.	2-N-{5-[[4-[2-(Methyl-2-pyridinylamino)-ethoxy]-phenyl]-methyl]-2,4-thiazolidindion}-bernsteinsäure, Verfahren zur Herstellung und Zusammensetzungen mit Rosiglitazonmaleat
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3856378T2 (de) *	1987-09-04	2000-05-11	Beecham Group P.L.C., Brentford	Substituierte Thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
KR19990036290A (ko) *	1995-08-10	1999-05-25	로즈 암스트롱	비인슐린 의존성 진성 당뇨병 환자에 대한 외인성 인슐린 투여량의 감소 방법
AU7604596A (en) *	1995-11-17	1997-06-11	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP0921798A1 (en) *	1996-07-12	1999-06-16	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Application Discontinuation
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/ko not_active Application Discontinuation
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/xx active
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2001521553A (ja)	2001-11-06
NO995938D0 (no)	1999-12-03
EA199901116A1 (ru)	2000-06-26
PL337201A1 (en)	2000-08-14
AR015120A1 (es)	2001-04-18
BR9810405A (pt)	2000-08-29
AP1214A (en)	2003-10-08
WO1998055122A1 (en)	1998-12-10
CN1430959A (zh)	2003-07-23
CA2292629A1 (en)	1998-12-10
AU8215098A (en)	1998-12-21
IL133074A0 (en)	2001-03-19
ID24264A (id)	2000-07-13
PE78899A1 (es)	1999-10-22
CA2292629C (en)	2004-01-06
KR20010013410A (ko)	2001-02-26
BG104048A (bg)	2000-07-31
NZ513922A (en)	2001-09-28
ZA984826B (en)	1999-08-03
NZ523725A (en)	2004-09-24
CO4940400A1 (es)	2000-07-24
UY25032A1 (es)	1998-11-26
HUP0004070A2 (hu)	2002-02-28
SK164899A3 (en)	2000-11-07
ZA9811572B (en)	1999-07-22
DZ2510A1 (fr)	2003-01-25
TR200002790T2 (tr)	2001-11-21
CN1259050A (zh)	2000-07-05
AP9901696A0 (en)	1999-12-31
EA002384B1 (ru)	2002-04-25
TW570797B (en)	2004-01-11
NO995938L (no)	2000-02-02
CN1526391A (zh)	2004-09-08
CN1112926C (zh)	2003-07-02
HUP0004070A3 (en)	2002-03-28
GB9711683D0 (en)	1997-08-06
AR008198A1 (es)	1999-12-29
MXPA99011322A (es)	2004-12-02
OA11306A (en)	2003-10-22
EP0998284A1 (en)	2000-05-10
CA2333352A1 (en)	1998-12-10
NO20040738L (no)	2000-02-02

Publication	Publication Date	Title
PL319833A1 (en)	1997-09-01	Compounds and composition for carrying active media
TR199902963T2 (xx)	2000-02-21	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip
BG105568A (en)	2002-01-31	Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
GEP20012388B (en)	2001-03-25	Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
EP0993831A3 (en)	2001-05-02	Compounds and compositions for delivering active agents
TW349946B (en)	1999-01-11	Novel naphthyl compounds and their process for preparation and pharmaceutical compositions containing same
PL341054A1 (en)	2001-03-26	Novel suppositiories containing an active compound being unstable in acid environments
GEP20043163B (en)	2004-01-26	Inhibitors of Caspases, Pharmaceutical Composition on its Base and Method for its Production
GEP20053479B (en)	2005-03-25	Pyrrolo[2,3-d]Pyrimidine Compounds, Pharmaceutical Composition Containing the Same and Use
GB2277872B (en)	1995-10-04	Pharmaceutical compositions containing nifedipine and process for the preparation thereof
GEP20032943B (en)	2003-04-25	Oral Composition of Levosimendan
EP2308496A3 (en)	2013-04-03	Formulation containing phosphate derivatives of electron transfer agents
ES2175104T3 (es)	2002-11-16	Composiciones farmaceuticas estables, bajo forma solida.
GEP20043298B (en)	2004-03-10	Branched Chain Amino Acid-Dependent Aminotransferase Inhibitors and Their Use in Treatment of Diabetic Retinopathy
MY135973A (en)	2008-07-31	Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
MX9708394A (es)	1998-02-28	Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUP0104206A2 (hu)	2002-04-29	(7alfa,17alfa)-17-Hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ont tartalmazó nagy tisztaságú készítmény és eljárás előállítására
IL124296A0 (en)	1998-12-06	Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
HK1001822A1 (en)	1998-07-10	Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
GB1535778A (en)	1978-12-13	Compounds useful in treatment of unipolar depression
TR199900141T2 (xx)	1999-03-22	Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
DK0527720T3 (da)	1994-12-05	Terapeutiske midler
NZ510672A (en)	2002-11-26	Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
MX9100974A (es)	1993-07-01	Enzima fibrinolitica hibrida y procedimiento para su preparacion.
ES2150400A6 (es)	2000-11-16	Una composicion para el tratamiento de desordenes ulcerosos del tracto gastrointestinal.